Today: 9 June 2026
Browse Category

NASDAQ:DXCM 7 July 2025 - 15 May 2026

US Stock Market Today: Nasdaq Futures Slide as Oil Shock and Treasury Yields Hit Wall Street

US Stock Market Today: Nasdaq Futures Slide as Oil Shock and Treasury Yields Hit Wall Street

U.S. stock futures dropped early Friday, with Nasdaq 100 E-minis down 1.56% and S&P 500 E-minis off 1.07%, as Treasury yields and oil prices surged. Brent crude climbed to $109.19 after Donald Trump warned Iran, while the 10-year Treasury yield hit 4.54%. April retail sales rose 0.5%, dampening hopes for a Fed rate cut. Beijing summit produced no clear breakthrough on Iran.
15 May 2026
······
Healthcare stocks head into Presidents Day break after Dexcom, Moderna lift XLV

Healthcare stocks head into Presidents Day break after Dexcom, Moderna lift XLV

The Health Care Select Sector SPDR Fund (XLV) rose 1.1% to $157.67 Friday, led by Dexcom’s 7.6% jump and Moderna’s 5.3% gain after earnings. Dexcom beat Q4 estimates and reiterated its 2026 outlook, while Moderna forecast up to 10% revenue growth, citing overseas markets. Broader markets saw tech lag as inflation data cooled. U.S. exchanges close Monday for Presidents Day.
15 February 2026
··
DexCom stock jumps in premarket after early Q4 sales and 2026 outlook; what DXCM investors watch next

DexCom stock jumps in premarket after early Q4 sales and 2026 outlook; what DXCM investors watch next

DexCom shares rose about 5% premarket Tuesday after the company reported preliminary Q4 revenue of $1.26 billion, up 13% year over year, and issued 2026 guidance above prior expectations. U.S. sales reached $892 million, with international revenue at $368 million. The company reaffirmed 2025 margin targets and raised 2026 goals. Barclays downgraded DexCom, citing competitive pressures despite strong sales.
13 January 2026
··
Accenture stock jumps 4% on fresh AI moves: Profitmind deal, Faculty buy plan

Accenture stock jumps 4% on fresh AI moves: Profitmind deal, Faculty buy plan

Accenture shares climbed 4.1% to $285.18 Thursday after the company announced a new AI partnership with Profitmind and a deal to buy UK-based Faculty. The Faculty acquisition, which adds over 400 staff, aims to expand Accenture’s “safe AI” offerings. Analyst Surinder Thind raised his price target to $290. General counsel Joel Unruch sold 1,332 shares at $275 each in a prearranged trade.
8 January 2026
·····
Global Wearable Health Tech News – June and July 2025

Global Wearable Health Tech News – June and July 2025

Biobeat’s cuffless vital-sign patch received FDA clearance and CE marking for remote hospital monitoring. PharmaSens and SiBionics unveiled the niia™ signature patch, combining a continuous glucose monitor and insulin pump, at ADA 2025. Fasikl’s Felix NeuroAI Wristband became the first FDA-cleared neuromodulation wearable for essential tremor. U.S. HHS Secretary RFK Jr. launched the MAHA initiative for nationwide wearable adoption.
7 July 2025
···

Stock Market Today

  • Coupang (CPNG) Shares Drop Amid Growth Investment; Valuation Seen Undervalued at $27.24
    June 9, 2026, 5:12 PM EDT. Coupang's stock declined over 11% in the past month and 35% year-to-date, pressured by ongoing net losses and aggressive investments. The South Korean e-commerce firm reported $35.13 billion in annual revenue but a $165 million net loss, driven by expansions in Product Commerce and Developing Offerings like delivery and fintech. At $15.18 per share, it's trading well below analysts' $27.24 fair value estimate, suggesting a 44% undervaluation. Improved operational efficiencies from automation and AI investments bolster long-term margin and earnings growth prospects. However, regulatory risks post-2025 data breach and losses in new markets like Taiwan pose challenges. Investors weigh Coupang's growth potential against near-term financial headwinds amid a volatile stock performance period.

Latest articles

RBC Stock Hits 52-Week High Even as TSX Falls

RBC Stock Hits 52-Week High Even as TSX Falls

9 June 2026
Royal Bank of Canada surged to a new 52-week high at C$277.09 before closing up 1.24% at C$276.01, outpacing the S&P/TSX’s 0.2% drop, after reporting Q2 net income of C$5.5 billion and adjusted EPS of C$3.90, beating estimates. Despite strong results and a 58.61% year-over-year gain, risks remain as the market is not cheap and investors await the Bank of Canada’s rate decision.
BigBear.ai Stock Drops as Panama AI Buzz Runs Into Dilution Worries

BigBear.ai Stock Drops as Panama AI Buzz Runs Into Dilution Worries

9 June 2026
BigBear.ai shares fell 33 cents to $3.98 as investors weighed a Panama cargo-security deployment, annual meeting results, and the company’s ongoing losses; despite a 14% backlog jump and $431.5 million in cash, revenue conversion remains uncertain, and a recent increase in authorized shares raises dilution risks.
Velo3D shares jump on gas-turbine order; VELO gains traction

Velo3D shares jump on gas-turbine order; VELO gains traction

9 June 2026
Velo3D shares soared 21% to $19.64 after announcing a gas-turbine manufacturing partnership with Aurelia Technologies using its Sapphire XC platform, expanding beyond aerospace and defense; no order value disclosed, so gains reflect expected future work as investors await Wednesday’s investor presentation.
Colorado PERA pay dispute spotlights mix of big bonuses and lower pensions

Colorado PERA pay dispute spotlights mix of big bonuses and lower pensions

9 June 2026
Colorado’s public pension fund paid $11.7 million in bonuses to investment staff after losing $9.8 billion in 2022, even as retirees’ checks lag inflation and the fund faces a $29 billion gap, fueling scrutiny over rising compensation while retirees and taxpayers absorb cuts and higher contributions.
Wall Street on Edge as Nasdaq AI Losses Deepen Before CPI, IPOs

Wall Street on Edge as Nasdaq AI Losses Deepen Before CPI, IPOs

9 June 2026
Nasdaq plunged 1.21% and S&P 500 fell 0.53% as tech and AI stocks resumed their sharp selloff, with the S&P tech index down over 4% at one point, while investors braced for Wednesday’s key CPI inflation data, Iran risks, and a wave of major IPOs that could force further stock rotation.
Go toTop